MRI back pain data won't change treatment results
The presence of common structural abnormalities identified by MRI in chronic nonspecific low back pain patients has no bearing on their responses to conservative treatment, according to a signficant study published in the journal Spine.
The presence of common structural abnormalities identified by MRI in chronic nonspecific low back pain patients has no bearing on their responses to conservative treatment, according to a signficant study published in the journal Spine.
Dr. Frank Kleinstuck and colleagues at the Schulthess Klinik's Spine Unit in Zurich prospectively obtained T2-weighted, 4-mm spin-echo MRI sequences of the lumbar spine of 53 chronic nonspecific low back pain patients prior to participation in a three-month exercise therapy program. They analyzed the presence or absence of abnormalities in relation to disability and back pain level (average to worst) before beginning the program, after its completion, and 12 months later. They found an association only between MRI-detected high-intensity zones and lower average pain at the 12-month follow-up.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
